首页 正文

Progress of KRAS G12C inhibitors in the treatment of refractory colorectal cancer and strategies for drug resistance response

{{output}}
Colorectal cancer is the third most prevalent cancer in the world. Early screening and detection of tumours, active surgical radical treatment, postoperative adjuvant chemotherapy, targeted therapy, and immunotherapy are performed based on pathological staging... ...